Cargando…
Botulinum toxin type A products are not interchangeable: a review of the evidence
Botulinum toxin type A (BoNTA) products are injectable biologic medications derived from Clostridium botulinum bacteria. Several different BoNTA products are marketed in various countries, and they are not interchangeable. Differences between products include manufacturing processes, formulations, a...
Autores principales: | Brin, Mitchell F, James, Charmaine, Maltman, John |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4199839/ https://www.ncbi.nlm.nih.gov/pubmed/25336912 http://dx.doi.org/10.2147/BTT.S65603 |
Ejemplares similares
-
Modulation of amygdala activity for emotional faces due to botulinum toxin type A injections that prevent frowning
por: Stark, Shauna, et al.
Publicado: (2023) -
Evidence to Use Botulinum Toxin Injections in Tension-Type Headache Management: A Systematic Review
por: Wieckiewicz, Mieszko, et al.
Publicado: (2017) -
Scientific review of the aesthetic uses of botulinum toxin type A
por: Park, Mee Young, et al.
Publicado: (2021) -
Microdroplet Botulinum Toxin: A Review
por: Kandhari, Rajat, et al.
Publicado: (2022) -
Interchangeability of Biosimilars: What Level of Clinical Evidence is Needed to Support the Interchangeability Designation in the United States?
por: Alvarez, Daniel F., et al.
Publicado: (2020)